FDA 483 - RLC Labs Inc. - November 02, 2023

RLC Labs Inc., an API Distributor and Dietary Supplement Manufacturer in Phoenix, AZ, was cited for a significant quality control deficiency. The firm failed to ensure the timely destruction of recalled drug products, despite a written commitment to the FDA made almost two years prior. This lapse indicates a failure of the quality control unit to fulfill its responsibilities and prevent the potential distribution of rejected drug products.